Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
A Global Prospective Observational Registry of Patients With Pompe Disease
for
Pompe Disease
Location: Durham NC, Fairfax VA, Atlanta GA, Pittsburgh PA,
Sponsor: Amicus Therapeutics
Sex: All
Age: 0+
Code: NCT06121011
Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Durham NC, Fairfax VA, Pittsburgh PA, Louisville KY,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase1, Phase2, Recruiting
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
for
Prostate Cancer
Location: Durham NC, Basking Ridge NJ, Middletown NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT06457919
Phase1, Phase2, Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
for
Multiple Myeloma
Location: Durham NC, Charlotte NC, Louisville KY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05828511
Phase1, Phase2, Recruiting
Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen
for
Tuberculosis, HIV Infections
Location: Durham NC
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 18+
Code: NCT00018083
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Durham NC, Knoxville TN, Washington D.C. DC, Atlanta GA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Renal Cell Carcinoma, Clear Cell
Location: Durham NC, Philadelphia PA, Nashville TN, Boston MA,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06708949
Phase2, Recruiting
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
for
Breast Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT01000883
Recruiting
Project Mountain - Comparing SpO2 and SaO2 for Accuracy